XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Statements of Assets and Liabilities - USD ($)
Mar. 31, 2023
Dec. 31, 2022
ASSETS    
Investments at fair value $ 185,897,000 [1] $ 149,586,000 [2]
Cash and cash equivalents 43,234,000 187,398,000
Interest Receivable 841,000 0
Deferred offering costs 278,000 382,000
Unrealized appreciation on foreign currency forward contracts 610,000 686,000
Receivable for investments sold 14,000 0
Total assets 230,874,000 338,052,000
LIABILITIES    
Payable for investments purchased 7,268,000 149,464,000
Cash collateral on forward currency contract 4,430,000 0
Management fees payable 329,000 33,000
Income incentive fee 443,000 0
Board of Managers fee payable 11,000 33,000
Accrued expenses and other liabilities 1,237,000 757,000
Total liabilities 13,718,000 150,287,000
Commitments and contingencies (Note 7)  
NET ASSETS    
Common shares 211,000 186,000
Additional paid in capital 210,948,000 186,232,000
Distributable earnings (loss) 5,997,000 1,347,000
Total net assets 217,156,000 187,765,000
Total liabilities and net assets $ 230,874,000 $ 338,052,000
Net asset value per share (in dollars per share) $ 10.32 $ 10.07
[1] Unless otherwise indicated, issuers of debt investments held by the Company (which such term “Company” shall include the Company’s subsidiaries for purposes of this Schedule of Investments) are denominated in dollars. All debt investments are income producing unless otherwise indicated.
[2] Unless otherwise indicated, issuers of debt investments held by the Company (which such term “Company” shall include the Company’s subsidiaries for purposes of this Schedule of Investments) are denominated in dollars. All debt investments are income producing unless otherwise indicated.